| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | 1 | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 0.50 |
—
—
—
|
| 2025 | 0.66 |
—
—
—
—
|
| 2024 | 0.66 |
—
—
—
—
|
| 2023 | 0.66 |
—
—
—
—
|
| 2022 | 0.66 |
—
—
—
—
|
| 2021 | 0.66 |
—
—
—
—
|
| 2020 | 0.66 |
—
—
—
—
|
| 2019 | 0.66 |
—
—
—
—
|
| 2018 | 0.66 |
—
—
—
—
|
| 2017 | 0.66 |
—
—
—
—
|
| 2016 | 0.66 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 328.54 | 353.69 | 366.25 | 455.09 |
| Receivables | 107.57 | 78.27 | 106.36 | 102.68 |
| Inventory | 493.86 | 462.08 | 482.98 | 479.65 |
| Other | 22.59 | 31.51 | 19.98 | 19.34 |
| 952.56 | 925.55 | 975.56 | 1,056.76 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 204.04 | 198.33 | 179.23 | 189.92 |
| ST’ Debt | 17.53 | 17.52 | 17.48 | 17.48 |
| Other | 101.00 | — | — | — |
| 330.53 | 320.62 | 302.90 | 329.21 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | 1,372.98 | 1,307.86 | 1,368.32 | — |
—
|
| ’25 | 1,288.12 | 1,331.27 | 1,346.22 | 1,368.42 |
5,334.03
|
| ’24 | 1,481.06 | 1,367.48 | 1,393.54 | 1,397.53 |
5,639.61
|
| ’23 | 1,493.31 | 1,380.60 | 1,433.87 | 1,585.00 |
5,892.78
|
| ’22 | 1,391.53 | 1,377.12 | 1,458.17 | 1,452.02 |
5,678.84
|
| ’21 | 1,190.44 | 1,184.56 | 1,277.47 | 1,335.46 |
4,987.92
|
| ’20 | 1,078.36 | 1,145.48 | 1,189.60 | 1,197.17 |
4,610.61
|
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | 38.41 | 83.80 | 66.98 | — |
—
|
| ’25 | (43.65) | 63.06 | 74.79 | 59.90 |
154.10
|
| ’24 | 15.54 | 70.43 | 103.28 | 73.26 |
262.52
|
| ’23 | 57.26 | 37.15 | 82.56 | 89.43 |
266.41
|
| ’22 | 94.98 | 60.50 | 106.12 | 77.90 |
339.50
|
| ’21 | 57.77 | 56.91 | 99.24 | 92.37 |
306.30
|
| ’20 | 16.25 | 159.11 | 53.60 | 121.16 |
350.12
|
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | 2.12 | 67.53 | 43.79 | — |
—
|
| ’25 | (77.51) | 39.02 | 45.77 | 36.88 |
44.16
|
| ’24 | (46.85) | 38.18 | 59.41 | 5.60 |
56.33
|
| ’23 | (0.93) | 5.76 | 36.94 | 54.54 |
96.32
|
| ’22 | 73.86 | 49.03 | 67.15 | 32.46 |
222.51
|
| ’21 | 24.13 | 22.47 | 65.88 | 70.83 |
183.31
|
| ’20 | (9.63) | 133.49 | 33.48 | 75.43 |
232.76
|
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | 1.48 | 1.28 | 1.36 | — |
—
|
| ’25 | 0.87 | 0.80 | 1.38 | 1.35 |
4.40
|
| ’24 | 2.28 | 1.68 | 1.67 | (0.08) |
5.56
|
| ’23 | 3.65 | 2.13 | 2.54 | 2.77 |
11.10
|
| ’22 | 3.48 | 3.61 | 3.57 | 3.69 |
14.36
|
| ’21 | 2.66 | 2.58 | 3.79 | 3.78 |
12.73
|
| ’20 | 0.87 | 1.99 | 3.10 | 2.86 |
8.82
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 74.63 | 73.38 | 59.73 | 58.92 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 102.99 | 99.65 | 89.59 | 78.59 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26,000 | 26,420 | 26,360 | 25,551 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.22 | 0.22 | 0.21 | 0.21 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,678.84 | 5,892.78 | 5,639.61 | 5,334.03 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.93% | 23.84% | 23.05% | 23.89% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 361.27 | 278.50 | 139.50 | 109.94 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.36% | 4.73% | 2.47% | 2.06% | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 272.76 | 210.81 | 105.54 | 83.59 | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 117.80 | 115.98 | 121.62 | 122.89 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 298.97 | 310.24 | 296.92 | 280.81 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 14.69 | 11.35 | 5.68 | 4.50 | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.87 | 14.03 | 13.82 | 8.11 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6.16) | (8.96) | (10.86) | (5.79) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.71 | 5.07 | 2.97 | 2.32 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 66.31 | 76.81 | 81.38 | 85.07 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.99 | 18.99 | 18.99 | 19.00 | — | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.39 | 6.64 | 13.13 | 15.49 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.26 | 0.24 | 0.25 | 0.25 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.19 | 0.98 | 0.92 | 0.82 | — | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.32 | 0.28 | 0.28 | 0.28 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.13 | 17.18 | 28.37 | 33.32 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 339.50 | 266.41 | 262.52 | 154.10 | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (116.99) | (170.10) | (206.18) | (109.94) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 222.51 | 96.32 | 56.33 | 44.16 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 504.35 | 622.02 | 604.93 | 672.65 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 571.91 | 553.22 | 535.01 | 516.44 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 304.71 | 224.68 | 181.32 | 150.19 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,259.59 | 1,458.97 | 1,545.75 | 1,615.93 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.65% | 8.84% | 4.22% | 3.28% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.06% | 10.85% | 5.32% | 4.16% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.32% | 15.51% | 7.03% | 5.29% | — | — | — |
ROE
|
Ingles Markets (IMKTA), a low-profile Southeast U.S. grocer with over 200 stores, rode a pandemic-fueled revenue boom—surging 55% to $5.89 billion in 2023—but has since stalled sharply, with 2024 sales down 4% to $5.64 billion and analysts forecasting another 5% drop in 2025. Revenue per share and per employee have reversed from peaks, signaling operational bloat amid post-COVID thrift, intensified competition from Walmart and Aldi, and softening same-store sales, while stock prices have decoupled downward only modestly from 2022 highs.
Profitability tells a grimmer tale: EBT margins halved to 2.5% in 2024 with a 62% plunge, EPS cratering 56% to $5.68, and gross margins eroding to 23.1% under sticky labor and supply costs. Despite a fortress-like balance sheet—debt slashed 39%, net debt down 79%, and equity up 227%—free cash flow per share has halved to $2.97, starving growth as capex intensifies and ROIC halves to 5.3%.
Trading at seemingly cheap multiples like 0.92x book value and 15x forward PE amid a 44-year dividend streak, Ingles appears undervalued versus peers—yet this masks a value trap in a consolidating industry facing Sun Belt consumer weakness, hurricane risks, and no insider action. Analysts see further EPS erosion to $4.50 in 2025; the contrarian verdict: structural headwinds prevail over cyclical recovery, warranting a sell on the dip.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.